TY - JOUR
AU - T. M. Abidogun
AU - T. O. Cole
AU - E. Massey
AU - M. Kleinman
AU - A. D. Greenblatt
AU - C. J. Seitz-Brown
AU - J. F. Magidson
AU - A. M. Belcher
A1 - 
AD - Department of Psychology, University of Maryland, College Park, United States of America.;Division of Addiction Research and Treatment, Department of Psychiatry, School of Medicine, University of Maryland, Baltimore, United States of America.;Division of Addiction Research and Treatment, Department of Psychiatry, School of Medicine, University of Maryland, Baltimore, United States of America. Electronic address: abelcher@som.umaryland.edu.
AN - 36880915
BT - J Subst Use Addict Treat
C5 - Opioids & Substance Use;Healthcare Disparities
DA - Feb
DO - 10.1016/j.josat.2022.208946
DP - NLM
ET - 20230107
JF - J Subst Use Addict Treat
LA - eng
PY - 2023
SN - 2949-8767 (Print);2949-8759
SP - 208946
ST - Patient experiences of COVID-19-induced changes to methadone treatment in a large community-based opioid treatment program in Baltimore
T1 - Patient experiences of COVID-19-induced changes to methadone treatment in a large community-based opioid treatment program in Baltimore
T2 - J Subst Use Addict Treat
TI - Patient experiences of COVID-19-induced changes to methadone treatment in a large community-based opioid treatment program in Baltimore
U1 - Opioids & Substance Use;Healthcare Disparities
U3 - 10.1016/j.josat.2022.208946
VL - 145
VO - 2949-8767 (Print);2949-8759
Y1 - 2023
ER -